Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of L. Roger Mason, Jr. as Chief Growth Officer On August 7, 2026, Dr. L. Roger Mason, Jr. resigned from his position as: (i) Senior Vice President and Chief Growth Officer of V2X, Inc.…
Filed Aug 10, 2026Accepted Aug 10, 2026, 4:35 PM EDTCIK 1601548Accession 0001628280-26-055284
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Resignation of L. Roger Mason, Jr. as Chief Growth Officer
On August 7, 2026, Dr. L. Roger Mason, Jr. resigned from his position as: (i) Senior Vice President and Chief Growth Officer of V2X, Inc. (the “Company”) and (ii) all positions held for each direct and indirect subsidiary of the Company, each effective immediately, to serve as the Director of the National Reconnaissance Office of the U.S. Department of War.
In anticipation of Dr. Mason’s resignation and in recognition for his contributions to the Company and for entering into a separation agreement and general release (the "Release Agreement"), dated August 6, 2026, with the Company, whereby Dr. Mason agreed to release all claims in favor of the Company, among other things, the Compensation and Human Capital Committee of the Board of Directors of the Company approved a payment to Dr. Mason in an amount of $331,975 (“AIP Payment”). The AIP Payment amount was equal to a prorated portion of his 2026 Annual Incentive Plan award at target based on the number of full months employed with the Company (from January 2026 through July 2026) prior to his confirmation as the Director of the National Reconnaissance Office of the U.S. Department of War.
Dr. Mason’s resignation from the Company is not a result of any disagreement with the Company on any matter relating to its operations, policies or practices. Mr. Jeremy C. Wensinger, the Company’s Chief Executive Officer, will assume Dr. Mason’s role and responsibilities until such time as Dr. Mason’s successor has been appointed.
The foregoing description of the Release Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Release Agreement, a copy of which is filed as Exhibit 10.1 hereto and incorporated herein by reference.